Elanco Animal Health 

$24.50
60
+$0.08+0.33% Friday 20:02
-$0.30-1.22%Friday 23:55After hours

Statistics

Day High
24.51
Day Low
24.45
52W High
27.98
52W Low
17.51
Volume
356,204
Avg. Volume
-
Mkt Cap
12.24B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

10NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
0.13
0.22
0.31
0.4
Expected EPS
0.205712
Actual EPS
N/A

Financials

-4.92%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
4.72BRevenue
-232MNet Income

Analyst Ratings

30.40Average Price Target
The highest estimate is 33.00.
From 5 ratings within the last 6 months. This is not an investment recommendation.
Buy
80%
Hold
20%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ELAN. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Zoetis
ZTS
Mkt Cap31.96B
Zoetis is a global leader in the discovery, development, manufacture, and commercialization of animal health medicines and vaccines, directly competing with Elanco in both the companion and livestock animal product markets.
Merck
MRK
Mkt Cap366B
Merck & Co., through its animal health division, offers veterinary pharmaceuticals, vaccines, and health management solutions and services, making it a direct competitor to Elanco in multiple segments of the animal health industry.
Phibro Animal Health
PAHC
Mkt Cap1.53B
Phibro Animal Health Corporation operates in the animal health and mineral nutrition markets, offering medicated feed additives, which puts it in direct competition with Elanco's product offerings.
Idexx Laboratories
IDXX
Mkt Cap43.72B
IDEXX Laboratories, Inc. provides diagnostic, detection, and information systems for veterinary, livestock, and poultry services, competing with Elanco in the animal health diagnostics market.
Abbott Laboratories
ABT
Mkt Cap194.62B
Abbott Laboratories, through its animal health division (before divestiture), offered products that competed with Elanco in diagnostics and nutrition, although its focus has shifted, it remains a competitor through legacy products and technologies.
Pfizer
PFE
Mkt Cap159.36B
Pfizer, prior to the spin-off of its animal health division into Zoetis, was a direct competitor in the development and commercialization of animal health products, and it maintains a presence in the market through ongoing investments and partnerships.
Elia Group SA/NV
ELI.BR
Mkt Cap14.92B
Elia System Operator provides infrastructure and services for the energy sector but is included erroneously as it does not compete in the animal health sector, illustrating the importance of accurate industry classification.

About

Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, poultry, and swine production.
Show more...
CEO
Jeffrey N. Simmons
Employees
9900
Country
United States
ISIN
US28414H1032
WKN
000A2N6BH

Listings

0 Comments

Share your thoughts

FAQ

What is Elanco Animal Health stock price today?
The current price of ELAN is $24.50 USD — it has increased by +0.33% in the past 24 hours. Watch Elanco Animal Health stock price performance more closely on the chart.
What is Elanco Animal Health stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on XNYS exchange Elanco Animal Health stocks are traded under the ticker ELAN.
Is Elanco Animal Health stock price growing?
ELAN stock has risen by +1.62% compared to the previous week, the month change is a -6.56% fall, over the last year Elanco Animal Health has showed a +32.94% increase.
What is Elanco Animal Health market cap?
Today Elanco Animal Health has the market capitalization of 12.24B
When is the next Elanco Animal Health earnings date?
Elanco Animal Health is going to release the next earnings report on November 10, 2026.
What were Elanco Animal Health earnings last quarter?
ELAN earnings for the last quarter are 0.34 USD per share, whereas the estimation was 0.27 USD resulting in a +26.3% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Elanco Animal Health revenue for the last year?
Elanco Animal Health revenue for the last year amounts to 4.72B USD.
What is Elanco Animal Health net income for the last year?
ELAN net income for the last year is -232M USD.
How many employees does Elanco Animal Health have?
As of September 05, 2026, the company has 9,900 employees.
In which sector is Elanco Animal Health located?
Elanco Animal Health operates in the Health & Wellness sector.
When did Elanco Animal Health complete a stock split?
Elanco Animal Health has not had any recent stock splits.
Where is Elanco Animal Health headquartered?
Elanco Animal Health is headquartered in INDIANAPOLIS, United States.